DigitalGlobe (DGI) EPS Estimated At $-0.03; 6 Analysts Are Bullish Theravance Biopharma (TBPH) Last Week

July 13, 2017 - By Adrian Mccoy

Among 7 analysts covering Theravance Biopharma (NASDAQ:TBPH), 6 have Buy rating, 1 Sell and 0 Hold. Therefore 86% are positive. Theravance Biopharma had 9 analyst reports since August 12, 2015 according to SRatingsIntel. As per Thursday, May 12, the company rating was initiated by Leerink Swann. The firm earned “Underperform” rating on Wednesday, October 12 by Robert W. Baird. The firm has “Overweight” rating by Piper Jaffray given on Thursday, November 3. The firm has “Neutral” rating given on Wednesday, August 12 by Robert W. Baird. Needham initiated it with “Buy” rating and $40 target in Wednesday, December 21 report. The firm has “Buy” rating by Guggenheim given on Monday, June 20. The firm earned “Buy” rating on Monday, August 29 by Evercore. See Theravance Biopharma Inc (NASDAQ:TBPH) latest ratings:

16/06/2017 Broker: Inc. – Ordinary Shares Rating: Cantor Fitzgerald 55

Analysts expect DigitalGlobe Inc (NYSE:DGI) to report $-0.03 EPS on July, 27.They anticipate $0.20 EPS change or 117.65% from last quarter’s $0.17 EPS. After having $-0.04 EPS previously, DigitalGlobe Inc’s analysts see -25.00% EPS growth. It closed at $33.4 lastly. It is down 48.46% since July 13, 2016 and is uptrending. It has outperformed by 31.76% the S&P500.

Since February 17, 2017, it had 0 buys, and 9 selling transactions for $3.07 million activity. 32,512 DigitalGlobe Inc (NYSE:DGI) shares with value of $1.03M were sold by JENSON WARREN. Scott Walter S. sold $209,420 worth of stock. On Friday, April 7 the insider ESTES HOWELL M sold $148,140. TORRES JOSE had sold 3,858 shares worth $122,492 on Monday, June 5.

Investors sentiment increased to 1.1 in Q4 2016. Its up 0.05, from 1.05 in 2016Q3. It improved, as 10 investors sold DigitalGlobe Inc shares while 70 reduced holdings. 36 funds opened positions while 52 raised stakes. 60.88 million shares or 1.40% less from 61.74 million shares in 2016Q3 were reported. Principal Fin Grp Inc reported 0% in DigitalGlobe Inc (NYSE:DGI). Sg Americas Securities reported 6,589 shares. The New Jersey-based Kcg Hldg has invested 0.01% in DigitalGlobe Inc (NYSE:DGI). Chicago Equity Ltd Limited Liability Company reported 138,255 shares. Rockefeller Service holds 468,274 shares. Rhumbline Advisers reported 0.01% of its portfolio in DigitalGlobe Inc (NYSE:DGI). Paloma Partners Management owns 86,813 shares. Elk Creek Ptnrs Limited Co reported 477,830 shares. Blackrock Institutional Trust Na has invested 0.01% in DigitalGlobe Inc (NYSE:DGI). The New Jersey-based Blackrock Investment Mngmt Lc has invested 0.01% in DigitalGlobe Inc (NYSE:DGI). Aperio Gp Inc Lc accumulated 7,150 shares. Blackrock Fund Advsr has invested 0.01% in DigitalGlobe Inc (NYSE:DGI). Asset Mgmt One Company Limited stated it has 0% of its portfolio in DigitalGlobe Inc (NYSE:DGI). Brown Advisory reported 1.58 million shares stake. 36,322 were accumulated by American Intl.

Among 7 analysts covering DigitalGlobe (NYSE:DGI), 1 have Buy rating, 0 Sell and 6 Hold. Therefore 14% are positive. DigitalGlobe had 13 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Friday, October 30 by Raymond James. JP Morgan downgraded it to “Neutral” rating and $27 target in Thursday, September 24 report. Dougherty & Company maintained DigitalGlobe Inc (NYSE:DGI) on Friday, July 29 with “Buy” rating. As per Tuesday, May 17, the company rating was downgraded by Morgan Stanley. The stock has “Buy” rating by Zacks on Tuesday, August 11. The rating was downgraded by Chardan Capital Markets to “Neutral” on Friday, February 26. The firm has “Buy” rating given on Monday, June 12 by Jefferies. The stock has “Hold” rating by Benchmark on Wednesday, September 23. Dougherty & Company downgraded the stock to “Neutral” rating in Monday, February 27 report. Benchmark maintained it with “Hold” rating and $24 target in Wednesday, October 26 report.

DigitalGlobe, Inc. is a provider of Earth imagery, data and analysis. The company has market cap of $2.08 billion. The Company’s imagery solutions and other services support a range of uses, including mission-planning, mapping and analysis, environmental monitoring, gas and oil exploration and infrastructure management. It has a 198.37 P/E ratio. The Company’s imagery solutions and other services are sourced from its own satellite constellation and third-party providers.

Since March 3, 2017, it had 0 buys, and 2 selling transactions for $1.30 million activity. On Friday, March 3 the insider Shafer Bradford J sold $854,772. HAUMANN BRETT K sold $440,975 worth of stock.

Investors sentiment increased to 1.73 in Q4 2016. Its up 0.02, from 1.71 in 2016Q3. It improved, as 20 investors sold Theravance Biopharma Inc shares while 13 reduced holdings. 19 funds opened positions while 38 raised stakes. 31.87 million shares or 27.84% more from 24.93 million shares in 2016Q3 were reported. Ameritas Prns owns 228 shares for 0% of their portfolio. Manufacturers Life Insurance The has invested 0% in Theravance Biopharma Inc (NASDAQ:TBPH). Moreover, Blackrock Advsrs Ltd has 0% invested in Theravance Biopharma Inc (NASDAQ:TBPH) for 21,411 shares. Zacks Investment Mngmt reported 12,248 shares or 0.01% of all its holdings. Live Your Vision reported 164 shares. Northern reported 473,554 shares. Ubs Asset Mngmt Americas holds 0% or 6,719 shares. Public Employees Retirement Association Of Colorado accumulated 0% or 12,100 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 1,658 shares for 0% of their portfolio. Blackrock Invest Mngmt Ltd Co reported 0.01% of its portfolio in Theravance Biopharma Inc (NASDAQ:TBPH). Sg Americas Secs Limited Liability Corporation holds 0.01% or 21,510 shares in its portfolio. Ny State Common Retirement Fund owns 38,200 shares for 0% of their portfolio. Proshare Advsr Ltd Co invested 0.01% of its portfolio in Theravance Biopharma Inc (NASDAQ:TBPH). Blackrock has 0% invested in Theravance Biopharma Inc (NASDAQ:TBPH). Jpmorgan Chase And Co owns 0% invested in Theravance Biopharma Inc (NASDAQ:TBPH) for 90,976 shares.

Theravance Biopharma, Inc. is a biopharmaceutical company. The company has market cap of $2.14 billion. The Firm is engaged in creating medicines for patients suffering from serious illness. It currently has negative earnings. The Firm operates in the segment of discovery , development and commercialization of human therapeutics.